Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥51.4bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥72.0bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥36.2bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥19.6bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥5.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥19.8bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥10.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥5.7bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥19.2bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥5.7bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥8.0bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥187.1bnat 2024-09-30Cons.Assets
Total assets¥171.6bnat 2024-03-31Cons.Assets
Total assets¥171.7bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥32.7bnat 2024-09-30Cons.Liabilities
Total liabilities¥27.9bnat 2024-03-31Cons.Liabilities
Net assets / equity¥154.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥143.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥140.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥67.3bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥50.6bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥84.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥65.3bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥70.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥74.3bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥23.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.6bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥245m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.9bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥377.232024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥212.672023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.182023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio83.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2024-04-01 → 2024-09-30¥50.1bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2024-04-01 → 2024-09-30¥50.1bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2024-04-01 → 2024-09-30¥18.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2024-04-01 → 2024-09-30¥676m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥19.6bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-09-30¥661m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥5.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 490
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember2212000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0583
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember2040000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0537
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember1843000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0486
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1677000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0442
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember1474000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0388
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember947000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0249
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember936000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0247
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember852000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0225
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember658000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0173
Number of shares heldCurrentQuarterInstant17528000
Shareholding ratioCurrentQuarterInstant0.4617
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember7972000
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember378297
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember37829700
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember138030
Number of shares issued shares voting rightsCurrentQuarterInstant45939730
Number of voting rights issued shares voting rightsCurrentQuarterInstant378297
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member7972000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member7972000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.1735
Number of shares held in own name treasury shares etcCurrentQuarterInstant7972000
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant7972000
Shareholding ratio treasury shares etcCurrentQuarterInstant0.1735
Cash and depositsPrior1YearInstant50625000000JPY
Cash and depositsCurrentQuarterInstant67289000000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant23744000000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant21024000000JPY
Short term investment securitiesPrior1YearInstant14699000000JPY
Short term investment securitiesCurrentQuarterInstant16697000000JPY
Merchandise and finished goodsPrior1YearInstant8062000000JPY
Merchandise and finished goodsCurrentQuarterInstant7317000000JPY
Work in processPrior1YearInstant2786000000JPY
Work in processCurrentQuarterInstant2572000000JPY
Raw materials and suppliesPrior1YearInstant6319000000JPY
Raw materials and suppliesCurrentQuarterInstant6972000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass